$AQB Cashflow Statement | Understand Stock

$AQB

$1.08 -$0.07 (6.09%) Close

$AQB Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities
Net loss
Adjustment to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Share-based compensation
Long-lived asset impairment
Loan forgiveness
Other non-cash items
Changes in operating assets and liabilities:
Inventory
Prepaid expenses and other assets
Accounts payable and accrued liabilities
Accrued employee compensation
Net cash used in operating activities
Investing activities
Purchases of and deposits on property, plant and equipment
Deposits on equipment purchases
Maturities of marketable securities
Purchases of marketable securities
Proceeds from asset sales
Other investing activities
Net cash provided by investing activities

Financing activities
Proceeds from issuance of debt
Repayment of term debt
Proceeds from the issuance of common stock, net
Proceeds from the exercise of stock options and warrants
Net cash provided by (used in) financing activities

Effect of exchange rate changes on cash and cash equivalents
Net change in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Cash and cash equivalents
Restricted cash
Supplemental disclosure of cash flow information and non-cash transactions:
Interest paid in cash from continuing operations
Interest paid in cash from discontinued operations
Non-cash conversion of accounts payable to current debt
Property and equipment included in accounts payable and accrued liabilities

Comments